Role of Prostaglandins and Non-steroid Anti-inflammatory Drugs in the Pathogenicity of Vaccinia Virus

References

1. Benavente J., Esteban M., Jaffe B. M., Santoro M. G. 1984; Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA₁ in vaccinia virus-infected cells. Journal of General Virology 65:599–608
   [Google Scholar]
2. Braun W., Ishizuka M. 1971; Antibody formation: reduced responses after administration of excessive amounts of non-specific stimulators. Proceedings of the National Academy of Sciences, U.S.A 68:1114–1116
   [Google Scholar]
3. Burch J. W., Baenziger N. L., Stanford N., Majerus P. W. 1978; Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin. Proceedings of the National Academy of Sciences, U.S.A 75:5181–5184
   [Google Scholar]
4. Ceuppens J. L., Goodwin J. S. 1982; Endogenous prostaglandin E₂ enhances polyclonal immunoglobulin production by tonically inhibiting T suppressor cell activity. Cellular Immunology 70:41–48
   [Google Scholar]
5. Eldor A., Fridman R., Vlodavsky I., Hyam E., Fuks Z., Panet A. 1984; Interferon enhances prostacyclin production by cultured vascular endothelial cells. Journal of Clinical Investigation 73:251–257
   [Google Scholar]
6. Ersten W., Emre R., Caudar A. D. 1980; An in vitro study on the effect of prostaglandins E₂ and F₂ alpha on E-rosette forming activity of normal lymphocytes. Prostaglandins 5:255–258
   [Google Scholar]
7. Giron D. J. 1982; Inhibition of viral replication in cell cultures treated with prostaglandin E₁. Proceedings of the Society for Experimental Biology and Medicine 170:25–28
   [Google Scholar]
8. Goodwin J. S., Ceuppens J. L. 1983; Effect of non-steroidal anti-inflammatory drugs in immune function. Seminars in Arthritis and Rheumatism 13:134–143
   [Google Scholar]
9. Goodwin J. S., Messner R. p., Peake G. T. 1978a; Inhibitors of T-cell mitogenesis: effect of mitogen dose. Cellular Immunology 45:303–308
   [Google Scholar]
10. Goodwin J. S., Selinger D. S., Messner R. P., Reed W. P. 1978b; Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infection and Immunity 19:430–433
    [Google Scholar]
11. Gordon D., Bray M., Morley J. 1976; Control of lymphokine secretion by prostaglandins. Nature; London: 262401–402
    [Google Scholar]
12. Halpin T. J., Holtzhawer F. J., Campbell R. J., Hall L. J., Correa-Villasenor A., Lanese R., Rice J., Hurwitz E. S. 1982; Reye’s syndrome and medication use. Journal of the American Medical Association 248:687–691
    [Google Scholar]
13. Harbour D. A., Blyth W. A., Hill T. J. 1978; Prostaglandins enhance spread of herpes simplex virus in cell cultures. Journal of General Virology 41:87–95
    [Google Scholar]
14. Jaffe E. A., Weksler B. B. 1979; Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin. Journal of Clinical Investigation 63:532–535
    [Google Scholar]
15. Kuzimiera D., Grinwich K. D., Plescia O. J. 1977; Tumor-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis. Prostaglandins 14:1175–1182
    [Google Scholar]
16. Luczak M., Gumulka W., Szwigielski S., Korbecki M. 1975; Inhibition of multiplication of parainfluenza 3 virus in prostaglandin-treated Wish cells. Archives of Virology 49:377–380
    [Google Scholar]
17. Marcus A. J. 1977; Aspirin and thromboembolism. A possible dilemma. New England Journal of Medicine 297:1284–1285
    [Google Scholar]
18. Masotti G., Galanti G., Pogesi L., Abbate R., Meriserneri G. G. 1979; Differential inhibition of prostacyclin production and platelet aggregation by aspirin. Lancet ii:1213–1216
    [Google Scholar]
19. Morito T., Bankhurst A. D., Williams R. C. 1980; Studies on the modulation of immunoglobulin production by prostaglandins. Prostaglandins 20:383–390
    [Google Scholar]
20. Moss B. 1985; Replication of poxviruses. In Virology pp. 685–703 Fields B. N. Edited by New York: Raven Press;
    [Google Scholar]
21. Mukherjee P. K., Simpson R. W. 1984; Indomethacin inhibits viral RNA and protein synthesis in cells infected with vesicular stomatitis virus. Virology 140:188–191
    [Google Scholar]
22. Rappaport R. S., Dodge G. R. 1982; Prostaglandin E. inhibits the production of human interleukin 2. Journal of Experimental Medicine 155:943–948
    [Google Scholar]
23. Santoro M. G., Benedetto A., Garruba G., Garaci E., Jaffe B. M. 1980; Prostaglandin A compounds as antiviral agents. Science 209:1032–1034
    [Google Scholar]
24. Santoro M. G., Jaffe B. M., Garaci E., Esteban M. 1982; Antiviral effect of prostaglandins of the A series; inhibition of vaccinia virus replication in cultured cells. Journal of General Virology 63:435–440
    [Google Scholar]
25. Santoro M. G., Jaffe B. M., Esteban M. 1983; Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein. Journal of General Virology 64:2797–2801
    [Google Scholar]
26. Snyder D. S., Beller D. I., Unanue E. R. 1982; Prostaglandins modulate macrophage la expression. Nature; London: 299163–165
    [Google Scholar]
27. Starko K. M., Ray C. G., Dominguez L. B., Stromberg W. L., Woodall D. F. 1980; Reye’s syndrome and salicylate use. Pediatrics 66:859–864
    [Google Scholar]
28. Stehle R. G. 1982; Physical chemistry, stability and handling of prostaglandins E₂, F_2α, D₂ and I₂: a critical summary. Methods in Enzymology 86:436–458
    [Google Scholar]
29. Waldman R. J., Hall W. N., McGee H., Van Amburg G. 1982; Aspirin as a risk factor in Reye’s syndrome. Journal of the American Medical Association 247:3089–3094
    [Google Scholar]
30. Walz-Cicconi M. A., Weller T. H. 1984; Dose-related effect of acetylsalicylic acid on replication of varicella zoster virus in vitro. Proceedings of the National Academy of Sciences, U.S.A 81:5223–5226
    [Google Scholar]